The patency of coronary bypass grafts is at the heart of CABG surgery. Transonic’s transit-time ultrasound technology offers cardiac surgeons assurance that the grafts they anastomose are patent. With unsurpassed accuracy, our products provide immediate, quantitative data to objectively assess the quality of an anastomosis.
Unseen blood flow obstructions can be detected immediately and repaired before closing the patient. Studies have shown that measuring flow intraoperatively reduces early graft failure following CABG surgery.
Benefits of these invaluable quantitative tools are:
Regardless of the nature of the defect you are correcting, your primary goal is to create and restore blood flow to its normal route through the heart and lungs so the child can thrive.
But waiting for a symptomatic acknowledgment after surgery is subjective and time-consuming.
Transonic’s COnfidence Flowprobes help you:
CABG is one of the most frequently performed surgeries around the world with nearly 250,000 operations performed annually in the United States alone. CABG surgery expends more resources than any other cardiovascular procedure.
As a hospital administrator, it’s a constant challenge to consolidate costs while maximizing value. Measuring flow during CABG is one example of a quality measure that meets both criteria.
Transonic’s flow measurement tools and technology provide cost savings by:
Using flow measurement tools can also have positive impacts on your facility’s reputation.
Surgery for implantation of a mechanical circulatory device is precarious and requires intense precision by the entire surgical team. Transonic’s Perivascular COnfidence Flowprobe can be used intraoperatively to provide additional security and assurance. The COnfidence Flowprobe can measure direct blood flow in the aorta or pulmonary artery during VAD implantation to maintain an appropriate Qp:Qs ratio for each and every patient.